Who should I contact about H.R.4317?

Modern Action routes the drafted message to your House representative when that is the relevant target for this bill, using your address to confirm constituent status.

What does Modern Action include in the message about H.R.4317?

The draft includes the bill number, your position, the reasons you selected, any personal context you add, and a direct ask such as voting yes, voting no, cosponsoring, opposing, or seeking changes.

In House Committee·Last action 322 days ago

Bill would tighten PBM rules in Medicare, Medicaid, and job-based plans

Q: How do I support or oppose H.R.4317?

Choose support, opposition, or changes. Modern Action uses that stance, the bill context, and any reasons you choose to draft a message you can review, edit, and send.

Officially: PBM Reform Act of 2025

This bill would add new rules for PBMs, the companies that manage drug benefits. It would protect pharmacy access in Medicare, require more price and rebate reporting, and ban spread pricing in Medicaid. Many of the biggest changes would start in 2028 or later, not right away.

Use this page to support, oppose, or ask Congress to amend H.R.4317. Modern Action explains PBM Reform Act of 2025 in plain English, helps identify the right senators or representative, and drafts a bill-specific message you can review before sending.

Where it stands

Sitting in Energy and Commerce

No vote scheduled. Constituent contact is what moves bills out of committee.

What this bill actually does

Medicare Part D plans would have to let in any pharmacy that agrees to the standard contract terms. HHS must define those "reasonable and relevant" terms by April 2028, and the rule starts being enforced in 2029.
Pharmacies would get a formal way to file complaints if a Medicare drug plan breaks the contract standards. HHS could investigate and use civil money penalties or other penalties if it finds a violation.
The bill creates a new category called "essential retail pharmacies" based on distance rules and whether an area lacks enough pharmacy access. HHS must publish reports at least every two years through 2034 comparing payments, network access, and patient out-of-pocket costs at those pharmacies and other pharmacies.

↓ Why your message matters here

This bill is sitting in committee with no scheduled vote — which means a small number of constituent messages can decide whether it moves forward or quietly dies.

Where your representatives stand

Enter your ZIP to see how your senators and member of Congress have voted, sponsored, or spoken on this bill.

The debate

What people are saying about this bill

✓Arguments in support

Increases Transparency: Supporters argue that the bill's reporting requirements will shed light on PBM practices, helping to prevent hidden costs and unfair pricing.
Lowers Drug Costs: By ensuring that rebates and discounts are passed on to patients, the bill could reduce out-of-pocket expenses for Medicare beneficiaries.
Protects Independent Pharmacies: The "any willing pharmacy" rule helps small pharmacies compete by allowing them to join Medicare networks.

✕Arguments against

Increased Administrative Costs: Critics might argue that the new reporting requirements could lead to higher administrative costs, which might be passed on to consumers.
Potential Stifling of Innovation: Some may worry that increased regulation could stifle innovation within the PBM industry.
Higher Premiums: There is a concern that transparency mandates could lead to higher premiums for Medicare plans.

Where this bill is in the process

Legislative timeline

✓

Introduced

Introduced in House

—

●

House Committee

Under House committee consideration

Latest: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (7/10/2025)

JUL 10

○

House Floor Vote

Voted on by House

—

○

Passed House

Approved by House

—

○

Senate Review

Sent to Senate for consideration

—

○

Passed Both Chambers

Approved by both House and Senate

—

○

Signed into Law

Signed by the President

—

For more detail

Read deeper

Questions people ask about contacting Congress on H.R.4317

How do I support or oppose H.R.4317, PBM Reform Act of 2025?

Choose one clear position: support, oppose, or amend. Then pick any reasons or personal context you want included. Modern Action uses that input and the bill context to draft a message you can review, edit, and send.

Who does Modern Action contact about this bill?

Congressional offices prioritize messages from their own constituents. Modern Action uses your address to route the drafted message to your House representative when that is the most relevant target for this bill.

What does Modern Action include in the message?

The draft includes the bill number, your position, the reasons you selected, any personal context you added, and a direct ask such as voting yes, voting no, cosponsoring, opposing, or seeking changes. You stay in control because you review it before it sends.

Take action on H.R.4317: PBM Reform Act of 2025

This page is for understanding PBM Reform Act of 2025, choosing whether you support it, oppose it, or want changes. Modern Action drafts the message before it goes to Congress.

Modern Action keeps the action tied to the bill itself: what it would do, where it is in the process (committee), which office can still act, and what ask belongs in the message.

You are not starting from a blank form. Modern Action drafts the message around H.R.4317, your stance, and the reasons you choose, then leaves the final review and edits to you.

Menu